In a report released yesterday, Chris Cooley from Stephens reiterated a Hold rating on Henry Schein (NASDAQ: HSIC), with a price target of $70. The company’s shares closed yesterday at $82.17.
According to TipRanks.com, Cooley is a 5-star analyst with an average return of 34.7% and a 75.0% success rate. Cooley covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Staar Surgical Company, and DENTSPLY SIRONA Inc.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Henry Schein with a $76.75 average price target.
See today’s analyst top recommended stocks >>
Henry Schein’s market cap is currently $12.66B and has a P/E ratio of 30.50. The company has a Price to Book ratio of 4.36.
Based on the recent corporate insider activity of 51 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments.
